Although the Chinese CoronaVac vaccine has not been fully approved or used in South Africa, SA is included with other third world countries in the Phase III trials of Sinovac’s coronavirus (Covid-19) vaccine on children and adolescents. The launch of the South African leg was recently held in Pretoria, South Africa, where approximately 2,000 children and adolescents from six months to 17 years will be enrolled, to test the safety and efficacy of the CoronaVac vaccine, although results from trials so far only show 50% effectiveness. The trials will test 14,000 children worldwide in Chile, the Philippines, Malaysia, Kenya and South Africa.
Continue reading…
China Testing Sinovac Vaccine on SA Children – Offers SinoVac Packaging Facility in SA as Sweetener!
Posted on Leave a comment
Cannabis Cultivation: South African Health Products Regulatory Authority (SAHPRA) awards first South African license
Posted on Leave a comment
Afriplex and House of Hemp have been granted the first medical cannabis cultivation license in South Africa. The compahasouse of Hemp have become the first to receive a Cannabis Cultivation License from the South African Health Products Regulatory Authority (SAHPRA). This represents a milestone in what is hoped will be a lucrative and innovative field,..
Continue reading…
New drug approved:- Cipla’s new triple-combination antiretroviral drug approved
Posted on Leave a comment
The South African Health Products Regulatory Authority (SAHPRA) has approved Cipla’s latest first-line triple-combination antiretroviral (ARV) treatment for HIV.
Continue reading…
Supply of medicine during strike by Sahpra will continue
Posted on Leave a comment
The South African Health Products Regulatory Authority (Sahpra) says it has developed contingency plans to ensure that its essential services are not disrupted during the ongoing protest action by the employees of the Department of Health.
Continue reading…
Valsartan, cardiovascular medication recalled in SA
Posted on Leave a comment
Certain medicines containing the active pharmaceutical ingredient, valsartan, have been recalled by the South African Health Products Regulatory Authority (Sahpra) due to an impurity that was found at one of the manufacturing facilities in China that produces the molecule.
Continue reading…